Program Overview

---

Medical College of Wisconsin

The Medical College of Wisconsin offers a comprehensive program for clinicians, nurses, and other healthcare professionals.

Program Description

The Lymphoma Tumor Board Conference 2026 is a series designed for clinicians, nurses, and allied health professionals to discuss the management of complex lymphoma cases. The program aims to provide a forum for participants to review and discuss appropriate management options, clinical trial availability, and recently published data that guide decision-making. The conference includes the review of pathology, radiological images, and clinical courses for each patient presented.

Key Words

• Lymphoma
• Treatment
• Pathology
• Leukemia

Target Audience

The target audience for this program includes:

• Physicians
• Nurse Practitioners
• Physician Assistants
• Nurses
• Pharmacists
• Psychologists
• Social Workers

Learning Objectives

Participants who engage in this educational intervention will be able to:

• Manage various complex lymphoma cases and review potential treatment options
• Utilize diagnostic and pathological tools to characterize a lymphoma
• Improve patient outcomes through group discussion

Faculty & Credentials

The planning committee for this program includes:

• Kaitlin Annunzio, MD (Activity Director), Assistant Professor, Department of Medicine, Division of Hematology & Oncology, The Medical College of Wisconsin
• Nirav Shah, MD, Associate Professor, Department of Medicine, Division of Hematology & Oncology, The Medical College of Wisconsin
• Kaitlin Annunzio, MD, Assistant Professor, Department of Medicine, Division of Hematology & Oncology, The Medical College of Wisconsin
• Sumana Devata, MD, Associate Professor, Department of Medicine, Division of Hematology & Oncology, The Medical College of Wisconsin
• Mehdi Hamadani, MD, Professor, Department of Medicine, Division of Hematology & Oncology, The Medical College of Wisconsin
• Walter Longo, MD, Professor, Department of Medicine, Division of Hematology & Oncology, The Medical College of Wisconsin

Disclosure of Financial Relationships

In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, all persons in control of content must disclose any relevant financial relationships. The following individuals had no relevant financial relationships to disclose:

• Kaitlin Annunzio, MD
• Walter Longo, MD

The following individuals disclosed financial relationships:

Nirav Shah, MD

• Loxo-Lilly: Advisory Board, Consultant, Researcher
• Miltenyi Biotec: Consultant, Researcher
• Genentech: Consultant, Researcher
• BMS/Juno: Consultant
• Galapagos: Consultant
• Abbvie: Consultant
• Seattle Genetics: Consultant
• Cargo Pharma: Consultant
• AstraZeneca: Consultant
• Tundra Therapeutics: Stock options

Sumana Devata, MD

• Novo Nordisk: Stock options
• AstraZeneca: Stock options
• Glaxo Smith Kline: Stock options
• Abbvie: Stock options
• Johnson & Johnson: Stock options
• Eli Lilly: Stock options
• Merck: Stock options
• Pfizer: Stock options
• Bayer: Stock options

Mehdi Hamadani, MD

• ADC Therapeutics: Consultant/Speaker/Researcher
• Spectrum Pharmaceuticals: Researcher
• Caribou: Consultant
• Omeros: Consultant
• BMS: Consultant
• Kite: Consultant, Speaker
• Genmab: Consultant
• CRISPR: Consultant
• Allovir: Consultant
• Autolus: Consultant
• Forte Bioscienes: Consultant
• Byondis: Consultant
• AstraZeneca: Speaker
• Beigene: Speaker
• Sobi: Speaker

Accreditation and Credit

ACCME Accreditation Statement

The Medical College of Wisconsin is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA Credit Designation Statement

The Medical College of Wisconsin designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit(s). Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Hours of Participation for Allied Health Care Professionals

The Medical College of Wisconsin designates this activity for up to 1.00 hours of participation for continuing education for allied health professionals.

Maintenance of Certification (MOC)

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to:

• 10 MOC points in the American Board of Pathology (ABPath) Maintenance of Certification (MOC) program
• 10 MOC points in the American Board of Internal Medicine (ABIM) Maintenance of Certification (MOC) program

Program Details

• Series date: 01/01/2026 - 8:00am CST to 12/31/2026 - 11:59pm CST
• Series location: Virtual Meeting, Milwaukee, WI, United States

Sessions

The following sessions are scheduled:

• 2026 Lymphoma Tumor Board: 01/12/2026 - 12:00pm to 1:00pm CST
• 2026 Lymphoma Tumor Board: 01/19/2026 - 12:00pm to 1:00pm CST
• 2026 Lymphoma Tumor Board: 02/09/2026 - 12:00pm to 1:00pm CST
• 2026 Lymphoma Tumor Board: 02/23/2026 - 12:00pm to 1:00pm CST
• 2026 Lymphoma Tumor Board: 03/09/2026 - 12:00pm to 1:00pm CDT
• 2026 Lymphoma Tumor Board: 03/23/2026 - 12:00pm to 1:00pm CDT